GeneDx Holdings Corp. (WGS)

GeneDx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	357.2	302.16	195.65	227.33	205.1	175.35
Other Revenue	5.13	3.29	6.91	7.36	7.1	3.97
Revenue	362.32	305.45	202.57	234.69	212.2	179.32
Revenue Growth (YoY)	48.70%	50.79%	-13.69%	10.60%	18.33%	-8.59%
Cost of Revenue	118.9	111	116.06	259.52	228.8	155.73
Gross Profit	243.42	194.45	86.51	-24.82	-16.6	23.6
Selling, General & Admin	182.11	166.93	191.49	338.24	324.39	173.32
Research & Development	50.76	45.57	55.09	86.2	105.16	72.7
Other Operating Expenses	3.41	3.41	5.27	6.31	-	-
Operating Expenses	236.28	215.91	251.85	430.76	429.55	246.02
Operating Income	7.14	-21.46	-165.34	-455.58	-446.15	-222.42
Interest Expense	-3	-3.03	-	-0.67	-2.84	-2.47
Interest & Investment Income	-	-	1.11	-	0.08	0.51
Other Non Operating Income (Expenses)	12.79	-13.6	1.17	60.09	198.22	0.02
EBT Excluding Unusual Items	16.93	-38.09	-163.06	-396.16	-250.69	-224.37
Merger & Restructuring Charges	-1.7	-1.75	-6.53	-1.93	-	-
Gain (Loss) on Sale of Assets	-	-	1.68	-	-	-
Asset Writedown	-	-	-10.4	-210.15	-	-
Legal Settlements	-12.79	-12.79	-	-	-	-
Other Unusual Items	-0.9	-	1.62	10.2	5.3	-16.97
Pretax Income	1.54	-52.63	-176.69	-598.03	-245.39	-241.34
Income Tax Expense	0.13	-0.34	-0.93	-49.05	-	-
Net Income	1.41	-52.29	-175.77	-548.98	-245.39	-241.34
Net Income to Common	1.41	-52.29	-175.77	-548.98	-245.39	-241.34
Shares Outstanding (Basic)	28	27	24	10	3	-
Shares Outstanding (Diluted)	29	27	24	10	3	-
Shares Change (YoY)	9.34%	10.61%	137.49%	212.57%	-	-
EPS (Basic)	0.05	-1.94	-7.23	-53.63	-74.93	-
EPS (Diluted)	0.05	-1.94	-7.23	-53.63	-74.93	-
Free Cash Flow	0.83	-33.99	-185.4	-326.31	-199.83	-117.22
Free Cash Flow Per Share	0.03	-1.26	-7.63	-31.88	-61.02	-
Gross Margin	67.18%	63.66%	42.71%	-10.58%	-7.82%	13.16%
Operating Margin	1.97%	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Profit Margin	0.39%	-17.12%	-86.77%	-233.91%	-115.64%	-134.59%
Free Cash Flow Margin	0.23%	-11.13%	-91.52%	-139.04%	-94.17%	-65.37%
EBITDA	29.6	-0.41	-138.21	-439.67	-429.94	-213.69
EBITDA Margin	8.17%	-0.13%	-68.23%	-187.34%	-202.62%	-119.17%
D&A For EBITDA	22.46	21.05	27.13	15.91	16.21	8.73
EBIT	7.14	-21.46	-165.34	-455.58	-446.15	-222.42
EBIT Margin	1.97%	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Revenue as Reported	362.32	305.45	202.57	234.69	212.2	179.32

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q